Alexander Fleming

Last updated

Sir

Alexander Fleming

FRS FRSE FRCS
Synthetic Production of Penicillin TR1468.jpg
Fleming in his laboratory c. 1943
Born(1881-08-06)6 August 1881
Darvel, East Ayrshire, Scotland
Died11 March 1955(1955-03-11) (aged 73)
London, England
Resting place St Paul's Cathedral
Alma mater
Known for Discovery of penicillin and lysozyme
Spouses
Awards
Scientific career
Fields Bacteriology, immunology
Signature
Alexander Fleming signature.svg

Sir Alexander Fleming FRS FRSE FRCS [1] (6 August 1881 – 11 March 1955) was a Scottish physician and microbiologist, best known for discovering the world's first broadly effective antibiotic substance, which he named penicillin. His discovery in 1928 of what was later named benzylpenicillin (or penicillin G) from the mould Penicillium rubens is described as the "single greatest victory ever achieved over disease." [3] [4] For this discovery, he shared the Nobel Prize in Physiology or Medicine in 1945 with Howard Florey and Ernst Boris Chain. [5] [6] [7]

Contents

He also discovered the enzyme lysozyme from his nasal discharge in 1922, and along with it a bacterium he named Micrococcus Lysodeikticus, later renamed Micrococcus luteus .

Fleming was knighted for his scientific achievements in 1944. [8] In 1999, he was named in Time magazine's list of the 100 Most Important People of the 20th century. In 2002, he was chosen in the BBC's television poll for determining the 100 Greatest Britons, and in 2009, he was also voted third "greatest Scot" in an opinion poll conducted by STV, behind only Robert Burns and William Wallace.

Early life and education

Born on 6 August 1881 at Lochfield farm near Darvel, in Ayrshire, Scotland, Alexander Fleming was the third of four children of farmer Hugh Fleming (1816–1888) and Grace Stirling Morton (1848–1928), the daughter of a neighbouring farmer. Hugh Fleming had four surviving children from his first marriage. He was 59 at the time of his second marriage to Grace, and died when Alexander was seven. [9]

Fleming went to Loudoun Moor School and Darvel School, and earned a two-year scholarship to Kilmarnock Academy before moving to London, where he attended the Royal Polytechnic Institution. [10] After working in a shipping office for four years, the twenty-year-old Alexander Fleming inherited some money from an uncle, John Fleming. His elder brother, Tom, was already a physician and suggested to him that he should follow the same career, and so in 1903, the younger Alexander enrolled at St Mary's Hospital Medical School in Paddington (now part of Imperial College London); he qualified with an MBBS degree from the school with distinction in 1906. [9]

Fleming, who was a private in the London Scottish Regiment of the Volunteer Force from 1900 [5] to 1914, [11] had been a member of the rifle club at the medical school. The captain of the club, wishing to retain Fleming in the team, suggested that he join the research department at St Mary's, where he became assistant bacteriologist to Sir Almroth Wright, a pioneer in vaccine therapy and immunology. In 1908, he gained a BSc degree with gold medal in Bacteriology, and became a lecturer at St Mary's until 1914.

Commissioned lieutenant in 1914 and promoted captain in 1917, [11] Fleming served throughout World War I in the Royal Army Medical Corps, and was Mentioned in Dispatches. He and many of his colleagues worked in battlefield hospitals at the Western Front in France. In 1918 he returned to St Mary's Hospital, where he was elected Professor of Bacteriology of the University of London in 1928. In 1951 he was elected the Rector of the University of Edinburgh for a term of three years. [9]

Scientific contributions

Antiseptics

During World War I, Fleming with Leonard Colebrook and Sir Almroth Wright joined the war efforts and practically moved the entire Inoculation Department of St Mary's to the British military hospital at Boulogne-sur-Mer. Serving as Temporary Lieutenant of the Royal Army Medical Corps, he witnessed the death of many soldiers from sepsis resulting from infected wounds. Antiseptics, which were used at the time to treat infected wounds, he observed, often worsened the injuries. [12] In an article published in the medical journal The Lancet in 1917, he described an ingenious experiment, which he was able to conduct as a result of his own glassblowing skills, in which he explained why antiseptics were killing more soldiers than infection itself during the war. Antiseptics worked well on the surface, but deep wounds tended to shelter anaerobic bacteria from the antiseptic agent, and antiseptics seemed to remove beneficial agents produced that protected the patients in these cases at least as well as they removed bacteria, and did nothing to remove the bacteria that were out of reach. [13] Wright strongly supported Fleming's findings, but despite this, most army physicians over the course of the war continued to use antiseptics even in cases where this worsened the condition of the patients. [9]

Discovery of lysozyme

At St Mary's Hospital, Fleming continued his investigations into bacteria culture and antibacterial substances. As his research scholar at the time V.D. Allison recalled, Fleming was not a tidy researcher and usually expected unusual bacterial growths in his culture plates. Fleming had teased Allison of his "excessive tidiness in the laboratory," and Allison rightly attributed such untidiness as the success of Fleming's experiments, and said, "[If] he had been as tidy as he thought I was, he would not have made his two great discoveries." [14]

In late 1921, while he was maintaining agar plates for bacteria, he found that one of the plates was contaminated with bacteria from the air. When he added nasal mucus, he found that the mucus inhibited the bacterial growth. [15] Surrounding the mucus area was a clear transparent circle (1 cm from the mucus), indicating the killing zone of bacteria, followed by a glassy and translucent ring beyond which was an opaque area indicating normal bacterial growth. In the next test, he used bacteria maintained in saline that formed a yellow suspension. Within two minutes of adding fresh mucus, the yellow saline turned completely clear. He extended his tests using tears, which were contributed by his co-workers. As Allison reminisced, saying, "For the next five or six weeks, our tears were the source of supply for this extraordinary phenomenon. Many were the lemons we used (after the failure of onions) to produce a flow of tears... The demand by us for tears was so great, that laboratory attendants were pressed into service, receiving threepence for each contribution." [14]

His further tests with sputum, cartilage, blood, semen, ovarian cyst fluid, pus, and egg white showed that the bactericidal agent was present in all of these. [16] He reported his discovery before the Medical Research Club in December and before the Royal Society the next year but failed to stir any interest, as Allison recollected:

I was present at this [Medical Research Club] meeting as Fleming's guest. His paper describing his discovery was received with no questions asked and no discussion, which was most unusual and an indication that it was considered to be of no importance. The following year he read a paper on the subject before the Royal Society, Burlington House, Piccadilly and he and I gave a demonstration of our work. Again with one exception little comment or attention was paid to it. [14]

Reporting in the 1 May 1922 issue of the Proceedings of the Royal Society B: Biological Sciences under the title "On a remarkable bacteriolytic element found in tissues and secretions," Fleming wrote:

In this communication I wish to draw attention to a substance present in the tissues and secretions of the body, which is capable of rapidly dissolving certain bacteria. As this substance has properties akin to those of ferments I have called it a "Lysozyme," and shall refer to it by this name throughout the communication. The lysozyme was first noticed during some investigations made on a patient suffering from acute coryza. [15]

This was the first recorded discovery of lysozyme. With Allison, he published further studies on lysozyme in October issue of the British Journal of Experimental Pathology the same year. [17] Although he was able to obtain larger amounts of lysozyme from egg whites, the enzyme was only effective against small counts of harmless bacteria, and therefore had little therapeutic potential. This indicates one of the major differences between pathogenic and harmless bacteria. [12] Described in the original publication, "a patient suffering from acute coryza" [15] was later identified as Fleming himself. His research notebook dated 21 November 1921 showed a sketch of the culture plate with a small note: “Staphyloid coccus from A.F.'s nose." [16] He also identified the bacterium present in the nasal mucus as Micrococcus Lysodeikticus, giving the species name (meaning "lysis indicator" for its susceptibility to lysozymal activity). [18] The species was reassigned as Micrococcus luteus in 1972. [19] The "Fleming strain" (NCTC2665) of this bacterium has become a model in different biological studies. [20] [21] The importance of lysozyme was not recognised, and Fleming was well aware of this, in his presidential address at the Royal Society of Medicine meeting on 18 October 1932, he said:

I choose lysozyme as the subject for this address for two reasons, firstly because I have a fatherly interest in the name, and, secondly, because its importance in connection with natural immunity does not seem to be generally appreciated. [22]

In his Nobel lecture on 11 December 1945, he briefly mentioned lysozyme, saying, "Penicillin was not the first antibiotic I happened to discover." [23] It was only towards the end of the 20th century that the true importance of Fleming's discovery in immunology was realised as lysozyme became the first antimicrobial protein discovered that constitute part of our innate immunity. [24] [25]

Discovery of penicillin

An advertisement advertising penicillin's "miracle cure" PenicillinPSAedit.jpg
An advertisement advertising penicillin's "miracle cure"

One sometimes finds what one is not looking for. When I woke up just after dawn on September 28, 1928, I certainly didn't plan to revolutionize all medicine by discovering the world's first antibiotic, or bacteria killer. But I suppose that was exactly what I did.

— Alexander Fleming [26]

Experiment

By 1927, Fleming had been investigating the properties of staphylococci. He was already well known from his earlier work, and had developed a reputation as a brilliant researcher. In 1928, he studied the variation of Staphylococcus aureus grown under natural condition, after the work of Joseph Warwick Bigger, who discovered that the bacterium could grow into a variety of types (strains). [27] On 3 September 1928, Fleming returned to his laboratory having spent a holiday with his family at Suffolk. Before leaving for his holiday, he inoculated staphylococci on culture plates and left them on a bench in a corner of his laboratory. [16] On his return, Fleming noticed that one culture was contaminated with a fungus, and that the colonies of staphylococci immediately surrounding the fungus had been destroyed, whereas other staphylococci colonies farther away were normal, famously remarking "That's funny". [28] Fleming showed the contaminated culture to his former assistant Merlin Pryce, who reminded him, "That's how you discovered lysozyme." [29] He identified the mould as being from the genus Penicillium. He suspected it to be P. chrysogenum, but a colleague Charles J. La Touche identified it as P. rubrum. (It was later corrected as P. notatum and then officially accepted as P. chrysogenum; in 2011, it was resolved as P. rubens.) [30] [31]

Commemorative plaque marking Fleming's discovery of penicillin at St Mary's Hospital, London Fleming's Plaque - geograph.org.uk - 1452410.jpg
Commemorative plaque marking Fleming's discovery of penicillin at St Mary's Hospital, London

The laboratory in which Fleming discovered and tested penicillin is preserved as the Alexander Fleming Laboratory Museum in St. Mary's Hospital, Paddington. The source of the fungal contaminant was established in 1966 as coming from La Touche's room, which was directly below Fleming's. [32] [33]

Fleming grew the mould in a pure culture and found that the culture broth contained an antibacterial substance. He investigated its anti-bacterial effect on many organisms, and noticed that it affected bacteria such as staphylococci and many other Gram-positive pathogens that cause scarlet fever, pneumonia, meningitis and diphtheria, but not typhoid fever or paratyphoid fever, which are caused by Gram-negative bacteria, for which he was seeking a cure at the time. It also affected Neisseria gonorrhoeae, which causes gonorrhoea, although this bacterium is Gram-negative. After some months of calling it "mould juice" or "the inhibitor", he gave the name penicillin on 7 March 1929 for the antibacterial substance present in the mould. [34]

Reception and publication

Fleming presented his discovery on 13 February 1929 before the Medical Research Club. His talk on "A medium for the isolation of Pfeiffer's bacillus" did not receive any particular attention or comment. Henry Dale, the then Director of National Institute for Medical Research and chair of the meeting, much later reminisced that he did not even sense any striking point of importance in Fleming's speech. [16] Fleming published his discovery in 1929 in the British Journal of Experimental Pathology, [35] but little attention was paid to the article. His problem was the difficulty of producing penicillin in large amounts, and moreover, isolation of the main compound. Even with the help of Harold Raistrick and his team of biochemists at the London School of Hygiene and Tropical Medicine, chemical purification was futile. "As a result, penicillin languished largely forgotten in the 1930s," as Milton Wainwright described. [36]

As late as in 1936, there was no appreciation for penicillin. When Fleming talked of its medical importance at the Second International Congress of Microbiology held in London, [37] [38] no one believed him. As Allison, his companion in both the Medical Research Club and international congress meeting, remarked the two occasions:

[Fleming at the Medical Research Club meeting] suggested the possible value of penicillin for the treatment of infection in man. Again there was a total lack of interest and no discussion. Fleming was keenly disappointed, but worse was to follow. He read a paper on his work on penicillin at a meeting of the International Congress of Microbiology, attended by the foremost bacteriologists from all over the world. There was no support for his views on its possible future value for the prevention and treatment of human infections and discussion was minimal. Fleming bore these disappointments stoically, but they did not alter his views or deter him from continuing his investigation of penicillin. [14]

In 1941, the British Medical Journal reported that "[Penicillin] does not appear to have been considered as possibly useful from any other point of view." [39] [40] [32]

Purification and stabilisation

3D-model of benzylpenicillin Penicillin-G 3D.png
3D-model of benzylpenicillin

In Oxford, Ernst Boris Chain and Edward Abraham were studying the molecular structure of the antibiotic. Abraham was the first to propose the correct structure of penicillin. [41] [42] Shortly after the team published its first results in 1940, Fleming telephoned Howard Florey, Chain's head of department, to say that he would be visiting within the next few days. When Chain heard that Fleming was coming, he remarked "Good God! I thought he was dead." [43]

Norman Heatley suggested transferring the active ingredient of penicillin back into water by changing its acidity. This produced enough of the drug to begin testing on animals. There were many more people involved in the Oxford team, and at one point the entire Sir William Dunn School of Pathology was involved in its production. After the team had developed a method of purifying penicillin to an effective first stable form in 1940, several clinical trials ensued, and their amazing success inspired the team to develop methods for mass production and mass distribution in 1945. [44] [45]

Fleming was modest about his part in the development of penicillin, describing his fame as the "Fleming Myth" and he praised Florey and Chain for transforming the laboratory curiosity into a practical drug. Fleming was the first to discover the properties of the active substance, giving him the privilege of naming it: penicillin. He also kept, grew, and distributed the original mould for twelve years, and continued until 1940 to try to get help from any chemist who had enough skill to make penicillin. Sir Henry Harris summed up the process in 1998 as: "Without Fleming, no Chain; without Chain, no Florey; without Florey, no Heatley; without Heatley, no penicillin." [46] The discovery of penicillin and its subsequent development as a prescription drug mark the start of modern antibiotics. [47]

Medical use and mass production

In his first clinical trial, Fleming treated his research scholar Stuart Craddock who had developed severe infection of the nasal antrum (sinusitis). The treatment started on 9 January 1929 but without any effect. It probably was due to the fact that the infection was with influenza bacillus (Haemophilus influenzae), the bacterium which he had found unsusceptible to penicillin. [32] Fleming gave some of his original penicillin samples to his colleague-surgeon Arthur Dickson Wright for clinical test in 1928. [48] [49] Although Wright reportedly said that it "seemed to work satisfactorily," [50] there are no records of its specific use. Cecil George Paine, a pathologist at the Royal Infirmary in Sheffield and former student of Fleming, was the first to use penicillin successfully for medical treatment. [36] He cured eye infections (conjunctivitis) of one adult and three infants (neonatal conjunctivitis) on 25 November 1930. [51]

Fleming in his laboratory in 1943 Professor Alexander Fleming at work in his laboratory at St Mary's Hospital, London, during the Second World War. D17801.jpg
Fleming in his laboratory in 1943

Fleming also successfully treated severe conjunctivitis in 1932. [3] [52] [53] Keith Bernard Rogers, who had joined St Mary's as medical student in 1929, [54] was captain of the London University rifle team and was about to participate in inter-hospital rifle shooting competition when he developed conjunctivitis. [55] [56] [57] Fleming applied his penicillin and cured Rogers before the competition. [3] [52] [58] It is said that the "penicillin worked and the match was won." However, the report that "Keith was probably the first patient to be treated clinically with penicillin ointment" [56] is no longer true as Paine's medical records showed up. [34]

There is a popular assertion both in popular and scientific literature that Fleming largely abandoned penicillin work in the early 1930s. [59] [60] [61] [62] In his review of André Maurois's The Life of Sir Alexander Fleming, Discoverer of Penicillin, William L. Kissick went so far as to say that "Fleming had abandoned penicillin in 1932... Although the recipient of many honors and the author of much scientific work, Sir Alexander Fleming does not appear to be an ideal subject for a biography." [63] This is a false, as Fleming continued to pursue penicillin research. [49] [64] As late as in 1939, Fleming's notebook shows attempts to make better penicillin production using different media. [34] In 1941, he published a method for assessment of penicillin effectiveness. [65] As to the chemical isolation and purification, Howard Florey and Ernst Boris Chain at the Radcliffe Infirmary in Oxford took up the research to mass-produce it, which they achieved with support from World War II military projects under the British and US governments. [66]

By mid-1942, the Oxford team produced the pure penicillin compound as yellow powder. [67] In August 1942, Harry Lambert (an associate of Fleming's brother Robert) was admitted to St Mary's Hospital due to life-threatening infection of the nervous system (streptococcal meningitis). [68] Fleming treated him with sulphonamides, but Lambert's condition deteriorated. He tested the antibiotic susceptibility and found that his penicillin could kill the bacteria. He requested Florey for the isolated sample. Florey sent the incompletely purified sample, which Fleming immediately administered into Lambert's spinal canal. Lambert showed signs of improvement the very next day, [14] and completely recovered within a week. [3] [69] Fleming published the clinical case in The Lancet in 1943. [70]

Upon this medical breakthrough, Allison informed the British Ministry of Health of the importance of penicillin and the need for mass production. The War Cabinet was convinced of the usefulness upon which Sir Cecil Weir, Director General of Equipment, called for a meeting on the mode of action on 28 September 1942. [71] [72] The Penicillin Committee was created on 5 April 1943. The committee consisted of Weir as chairman, Fleming, Florey, Sir Percival Hartley, Allison and representatives from pharmaceutical companies as members. The main goals were to produce penicillin rapidly in large quantities with collaboration of American companies, and to supply the drug exclusively for Allied armed forces. [14] By D-Day in 1944, enough penicillin had been produced to treat all the wounded of the Allied troops. [73]

Antibiotic resistance

Modern antibiotics are tested using a method similar to Fleming's discovery. Staphylococcus aureus (AB Test).jpg
Modern antibiotics are tested using a method similar to Fleming's discovery.

Fleming also discovered very early that bacteria developed antibiotic resistance whenever too little penicillin was used or when it was used for too short a period. Almroth Wright had predicted antibiotic resistance even before it was noticed during experiments. Fleming cautioned about the use of penicillin in his many speeches around the world. On 26 June 1945, he made the following cautionary statements: "the microbes are educated to resist penicillin and a host of penicillin-fast organisms is bred out ... In such cases the thoughtless person playing with penicillin is morally responsible for the death of the man who finally succumbs to infection with the penicillin-resistant organism. I hope this evil can be averted." [74] He cautioned not to use penicillin unless there was a properly diagnosed reason for it to be used, and that if it were used, never to use too little, or for too short a period, since these are the circumstances under which bacterial resistance to antibiotics develops. [75]

It had been experimentally shown in 1942 that S. aureus could develop penicillin resistance under prolonged exposure. [76] Elaborating the possibility of penicillin resistance in clinical conditions in his Nobel Lecture, Fleming said:

The time may come when penicillin can be bought by anyone in the shops. Then there is the danger that the ignorant man may easily underdose himself and by exposing his microbes to non-lethal quantities of the drug make them resistant. [23]

It was around that time that the first clinical case of penicillin resistance was reported. [77]

Personal life

Grave of Sir Alexander Fleming in the crypt of St Paul's Cathedral, London St-Pauls-Cathedral London Plaque-for-Sir-Alexander-Fleming-01.jpg
Grave of Sir Alexander Fleming in the crypt of St Paul's Cathedral, London

On 24 December 1915, Fleming married a trained nurse, Sarah Marion McElroy of Killala, County Mayo, Ireland. Their only child, Robert Fleming (1924–2015), became a general medical practitioner. After his first wife's death in 1949, Fleming married Amalia Koutsouri-Vourekas, a Greek colleague at St. Mary's, on 9 April 1953; she died in 1986. [78]

Fleming came from a Presbyterian background, while his first wife Sarah was a (lapsed) Roman Catholic. It is said that he was not particularly religious, and their son Robert was later received into the Anglican church, while still reportedly inheriting his two parents' fairly irreligious disposition. [79]

When Fleming learned of Robert D. Coghill and Andrew J. Moyer patenting the method of penicillin production in US in 1944, [80] he was furious, and commented:

I found penicillin and have given it free for the benefit of humanity. Why should it become a profit-making monopoly of manufacturers in another country? [14]

From 1921 until his death in 1955, Fleming owned a country home named "The Dhoon" in Barton Mills, Suffolk. [4] [81]

Death

On 11 March 1955, Fleming died at his home in London of a heart attack. His ashes are buried in St Paul's Cathedral. [2]

Awards and legacy

Display of Fleming's awards, including his Nobel Prize. Also shows a sample of penicillin and an example of an early apparatus for preparing it. Flemingawardsnationalmuseumofscotland.jpg
Display of Fleming's awards, including his Nobel Prize. Also shows a sample of penicillin and an example of an early apparatus for preparing it.
Sir Alexander Fleming (centre) receiving the Nobel prize from King Gustaf V of Sweden (right) in 1945 Nobelpristagare Fleming Midi.jpg
Sir Alexander Fleming (centre) receiving the Nobel prize from King Gustaf V of Sweden (right) in 1945
Faroe Islands postage stamp commemorating Fleming Faroe stamp 079 europe (fleming).jpg
Faroe Islands postage stamp commemorating Fleming
Barcelona to Sir Alexander Fleming (1956), by Catalan sculptor Josep Manuel Benedicto. Barcelona: jardins del Doctor Fleming. Barcelona a Sir Alexander Fleming.JPG
Barcelona to Sir Alexander Fleming (1956), by Catalan sculptor Josep Manuel Benedicto. Barcelona: jardins del Doctor Fleming.

Fleming's discovery of penicillin changed the world of modern medicine by introducing the age of useful antibiotics; penicillin has saved, and is still saving, millions of people around the world. [82]

The laboratory at St Mary's Hospital where Fleming discovered penicillin is home to the Fleming Museum, a popular London attraction. His alma mater, St Mary's Hospital Medical School, merged with Imperial College London in 1988. The Sir Alexander Fleming Building on the South Kensington campus was opened in 1998, where his son Robert and his great-granddaughter Claire were presented to the Queen; it is now one of the main preclinical teaching sites of the Imperial College School of Medicine.

His other alma mater, the Royal Polytechnic Institution (now the University of Westminster) has named one of its student halls of residence Alexander Fleming House, which is near to Old Street.

Myths

The Fleming myth

By 1942, penicillin, produced as pure compound, was still in short supply and not available for clinical use. When Fleming used the first few samples prepared by the Oxford team to treat Harry Lambert who had streptococcal meningitis, [3] the successful treatment was a major news, particularly popularised in The Times . Wright was surprised to discover that Fleming and the Oxford team were not mentioned, though Oxford was attributed as the source of the drug. Wright wrote to the editor of The Times, which eagerly interviewed Fleming, but Florey prohibited the Oxford team from seeking media coverage. As a consequence, only Fleming was widely publicised in the media, [94] which led to the misconception that he was entirely responsible for the discovery and development of the drug. [95] Fleming himself referred to this incident as "the Fleming myth." [96] [97]

The Churchills

The popular story [98] of Winston Churchill's father paying for Fleming's education after Fleming's father saved young Winston from death is false. [95] According to the biography, Penicillin Man: Alexander Fleming and the Antibiotic Revolution by Kevin Brown, Alexander Fleming, in a letter [99] to his friend and colleague Andre Gratia, [100] described this as "A wondrous fable." Nor did he save Winston Churchill himself during World War II. Churchill was saved by Lord Moran, using sulphonamides, since he had no experience with penicillin, when Churchill fell ill in Carthage in Tunisia in 1943. The Daily Telegraph and The Morning Post on 21 December 1943 wrote that he had been saved by penicillin. He was saved by the new sulphonamide drug Sulphapyridine, known at the time under the research code M&B 693, discovered and produced by May & Baker Ltd, Dagenham, Essex – a subsidiary of the French group Rhône-Poulenc. In a subsequent radio broadcast, Churchill referred to the new drug as "This admirable M&B". [101] It is highly probable that the correct information about the sulphonamide did not reach the newspapers because, since the original sulphonamide antibacterial, Prontosil, had been a discovery by the German laboratory Bayer, and as Britain was at war with Germany at the time, it was thought better to raise British morale by associating Churchill's cure with a British discovery, penicillin.[ citation needed ]

See also

Related Research Articles

<span class="mw-page-title-main">Antibiotic</span> Antimicrobial substance active against bacteria

An antibiotic is a type of antimicrobial substance active against bacteria. It is the most important type of antibacterial agent for fighting bacterial infections, and antibiotic medications are widely used in the treatment and prevention of such infections. They may either kill or inhibit the growth of bacteria. A limited number of antibiotics also possess antiprotozoal activity. Antibiotics are not effective against viruses such as the common cold or influenza; drugs which inhibit growth of viruses are termed antiviral drugs or antivirals rather than antibiotics. They are also not effective against fungi; drugs which inhibit growth of fungi are called antifungal drugs.

<span class="mw-page-title-main">Penicillin</span> Group of antibiotics derived from Penicillium fungi

Penicillins are a group of β-lactam antibiotics originally obtained from Penicillium moulds, principally P. chrysogenum and P. rubens. Most penicillins in clinical use are synthesised by P. chrysogenum using deep tank fermentation and then purified. A number of natural penicillins have been discovered, but only two purified compounds are in clinical use: penicillin G and penicillin V. Penicillins were among the first medications to be effective against many bacterial infections caused by staphylococci and streptococci. They are still widely used today for different bacterial infections, though many types of bacteria have developed resistance following extensive use.

<span class="mw-page-title-main">Howard Florey</span> 20th-century Australian pathologist

Howard Walter Florey, Baron Florey was an Australian pharmacologist and pathologist who shared the Nobel Prize in Physiology or Medicine in 1945 with Sir Ernst Chain and Sir Alexander Fleming for his role in the development of penicillin.

<span class="mw-page-title-main">Beta-lactam antibiotics</span> Class of broad-spectrum antibiotics

β-lactam antibiotics are antibiotics that contain a beta-lactam ring in their chemical structure. This includes penicillin derivatives (penams), cephalosporins and cephamycins (cephems), monobactams, carbapenems and carbacephems. Most β-lactam antibiotics work by inhibiting cell wall biosynthesis in the bacterial organism and are the most widely used group of antibiotics. Until 2003, when measured by sales, more than half of all commercially available antibiotics in use were β-lactam compounds. The first β-lactam antibiotic discovered, penicillin, was isolated from a strain of Penicillium rubens.

<i>Penicillium</i> Genus of fungi

Penicillium is a genus of ascomycetous fungi that is part of the mycobiome of many species and is of major importance in the natural environment, in food spoilage, and in food and drug production.

<span class="mw-page-title-main">Streptomycin</span> Aminoglycoside antibiotic

Streptomycin is an antibiotic medication used to treat a number of bacterial infections, including tuberculosis, Mycobacterium avium complex, endocarditis, brucellosis, Burkholderia infection, plague, tularemia, and rat bite fever. For active tuberculosis it is often given together with isoniazid, rifampicin, and pyrazinamide. It is administered by injection into a vein or muscle.

<span class="mw-page-title-main">Selman Waksman</span> Ukraine Jewish-American biochemist, microbiologist and Nobel Laureate (1888–1973)

Selman Abraham Waksman was a Jewish Russian-born American inventor, Nobel Prize laureate, biochemist and microbiologist whose research into the decomposition of organisms that live in soil enabled the discovery of streptomycin and several other antibiotics. A professor of biochemistry and microbiology at Rutgers University for four decades, he discovered a number of antibiotics, and he introduced procedures that have led to the development of many others. The proceeds earned from the licensing of his patents funded a foundation for microbiological research, which established the Waksman Institute of Microbiology located on the Rutgers University Busch Campus in Piscataway, New Jersey (USA). In 1952, he was awarded the Nobel Prize in Physiology or Medicine for "ingenious, systematic and successful studies of the soil microbes that led to the discovery of streptomycin." Waksman and his foundation later were sued by Albert Schatz, one of his PhD students and the discoverer of streptomycin, for minimizing Schatz's role in the discovery.

<span class="mw-page-title-main">Ernst Chain</span> German-born British biochemist (1906–1979)

Sir Ernst Boris Chain was a German-born British biochemist best known for being a co-recipient of the Nobel Prize in Physiology or Medicine for his work on penicillin.

<span class="mw-page-title-main">Edward Abraham</span> English biochemist

Sir Edward Penley Abraham, was an English biochemist instrumental in the development of the first antibiotics penicillin and cephalosporin.

An antimicrobial is an agent that kills microorganisms or stops their growth. Antimicrobial medicines can be grouped according to the microorganisms they act primarily against. For example, antibiotics are used against bacteria, and antifungals are used against fungi. They can also be classified according to their function. Agents that kill microbes are microbicides, while those that merely inhibit their growth are called bacteriostatic agents. The use of antimicrobial medicines to treat infection is known as antimicrobial chemotherapy, while the use of antimicrobial medicines to prevent infection is known as antimicrobial prophylaxis.

<span class="mw-page-title-main">Almroth Wright</span> British microbiologist and immunologist (1861-1947)

Sir Almroth Edward Wright was a British bacteriologist and immunologist.

<span class="mw-page-title-main">Albert Schatz (scientist)</span> American microbiologist and antibiotic discoverer (1920–2005)

Albert Israel Schatz was an American microbiologist and academic who discovered streptomycin, the first antibiotic known to be effective for the treatment of tuberculosis. He graduated from Rutgers University in 1942 with a bachelor's degree in soil microbiology, and received his doctorate from Rutgers in 1945. His PhD research led directly to the discovery of streptomycin.

Production of antibiotics is a naturally occurring event, that thanks to advances in science can now be replicated and improved upon in laboratory settings. Due to the discovery of penicillin by Alexander Flemming, and the efforts of Florey and Chain in 1938, large-scale, pharmaceutical production of antibiotics has been made possible. As with the initial discovery of penicillin, most antibiotics have been discovered as a result of happenstance. Antibiotic production can be grouped into three methods: natural fermentation, semi-synthetic, and synthetic. As more and more bacteria continue to develop resistance to currently produced antibiotics, research and development of new antibiotics continues to be important. In addition to research and development into the production of new antibiotics, repackaging delivery systems is important to improving efficacy of the antibiotics that are currently produced. Improvements to this field have seen the ability to add antibiotics directly into implanted devices, aerosolization of antibiotics for direct delivery, and combination of antibiotics with non antibiotics to improve outcomes. The increase of antibiotic resistant strains of pathogenic bacteria has led to an increased urgency for the funding of research and development of antibiotics and a desire for production of new and better acting antibiotics.

<span class="mw-page-title-main">Flucloxacillin</span> Penicillin

Flucloxacillin, also known as floxacillin, is an antibiotic used to treat skin infections, external ear infections, infections of leg ulcers, diabetic foot infections, and infection of bone. It may be used together with other medications to treat pneumonia, and endocarditis. It may also be used prior to surgery to prevent Staphylococcus infections. It is not effective against methicillin-resistant Staphylococcus aureus (MRSA). It is taken by mouth or given by injection into a vein or muscle.

<span class="mw-page-title-main">History of penicillin</span> Aspect of medical history

The history of penicillin follows a number of observations and discoveries of apparent evidence of antibiotic activity of the mould Penicillium that led to the development of penicillins that became the most widely used antibiotics. Following the identification of Penicillium rubens as the source of the compound in 1928 and with the production of pure compound in 1942, penicillin became the first naturally derived antibiotic. There are anecdotes about ancient societies using moulds to treat infections, and in the following centuries many people observed the inhibition of bacterial growth by various moulds. However, it is unknown if the species involved were Penicillium species or if the antimicrobial substances produced were penicillin.

<span class="mw-page-title-main">Medical microbiology</span> Branch of medical science

Medical microbiology, the large subset of microbiology that is applied to medicine, is a branch of medical science concerned with the prevention, diagnosis and treatment of infectious diseases. In addition, this field of science studies various clinical applications of microbes for the improvement of health. There are four kinds of microorganisms that cause infectious disease: bacteria, fungi, parasites and viruses, and one type of infectious protein called prion.

<i>Penicillium rubens</i> Species of fungus

Penicillium rubens is a species of fungus in the genus Penicillium and was the first species known to produce the antibiotic penicillin. It was first described by Philibert Melchior Joseph Ehi Biourge in 1923. For the discovery of penicillin from this species Alexander Fleming shared the Nobel Prize in Physiology or Medicine in 1945. The original penicillin-producing type has been variously identified as Penicillium rubrum, P. notatum, and P. chrysogenum among others, but genomic comparison and phylogenetic analysis in 2011 resolved that it is P. rubens. It is the best source of penicillins and produces benzylpenicillin (G), phenoxymethylpenicillin (V) and octanoylpenicillin (K). It also produces other important bioactive compounds such as andrastin, chrysogine, fungisporin, roquefortine, and sorbicillins.

<span class="mw-page-title-main">Bacteriologist</span> Professional trained in bacteriology

A bacteriologist is a microbiologist, or similarly trained professional, in bacteriology -- a subdivision of microbiology that studies bacteria, typically pathogenic ones. Bacteriologists are interested in studying and learning about bacteria, as well as using their skills in clinical settings. This includes investigating properties of bacteria such as morphology, ecology, genetics and biochemistry, phylogenetics, genomics and many other areas related to bacteria like disease diagnostic testing. Alongside human and animal healthcare providers, they may carry out various functions as medical scientists, veterinary scientists, or diagnostic technicians in locations like clinics, blood banks, hospitals, laboratories and animal hospitals. Bacteriologists working in public health or biomedical research help develop vaccines for public use.

John Charles Sherris was an English-American medical doctor, pathologist, and bacteriologist. He was the president of the American Society for Microbiology (ASM) in 1983.

Mary Ethel Florey, Baroness Florey was an Australian doctor and medical scientist. Her work was instrumental in the discovery of penicillin. She was part of the team that ran the first trials on penicillin and first administered the drug in a human trial. Part of her research has been summarized in a four volume book on antibiotics published from 1952 to 1960.

References

  1. 1 2 3 Colebrook, L. (1956). "Alexander Fleming 1881–1955". Biographical Memoirs of Fellows of the Royal Society . 2: 117–126. doi:10.1098/rsbm.1956.0008. JSTOR   769479. S2CID   71887808.
  2. 1 2 "Sir Alexander Fleming – Biography". Nobel Foundation. Retrieved 25 October 2011.
  3. 1 2 3 4 5 Bennett, Joan W; Chung, King-Thom (2001), "Alexander Fleming and the discovery of penicillin", Advances in Applied Microbiology, Elsevier, 49: 163–184, doi:10.1016/s0065-2164(01)49013-7, ISBN   978-0-12-002649-4, PMID   11757350 , retrieved 17 October 2020
  4. 1 2 Ligon, B. Lee (2004). "Sir Alexander Fleming: Scottish researcher who discovered penicillin". Seminars in Pediatric Infectious Diseases. 15 (1): 58–64. doi:10.1053/j.spid.2004.02.002. PMID   15175996.
  5. 1 2 3 "Alexander Fleming Biography". Les Prix Nobel. The Nobel Foundation. 1945. Archived from the original on 30 January 2011. Retrieved 27 March 2011.
  6. ↑ Hugh, TB (2002). "Howard Florey, Alexander Fleming and the fairy tale of penicillin". The Medical Journal of Australia. 177 (1): 52–53, author 53 53. doi:10.5694/j.1326-5377.2002.tb04643.x. PMID   12436980. S2CID   222048204.
  7. ↑ Cruickshank, Robert (1955). "Sir Alexander Fleming, F.R.S". Nature. 175 (4459): 355–6. Bibcode:1955Natur.175..663C. doi: 10.1038/175663a0 . PMC   1023893 . PMID   13271592.
  8. ↑ McIntyre, N (2007). "Sir Alexander Fleming". Journal of Medical Biography. 15 (4): 234. doi:10.1258/j.jmb.2007.05-72. PMID   18615899. S2CID   77187550.
  9. 1 2 3 4 Mazumdar, PM (1984). "Fleming as Bacteriologist: Alexander Fleming". Science. 225 (4667): 1140–1141. Bibcode:1984Sci...225.1140C. doi:10.1126/science.225.4667.1140. PMID   17782415.
  10. ↑ Brown, Kevin (2004). Penicillin man : Alexander Fleming and the antibiotic revolution. Stroud: Sutton. ISBN   978-0-7509-3152-6 . Retrieved 11 September 2015.
  11. 1 2 3 4 5 Kelly's Handbook to the Titled, Landed and Official Classes, 1955. Kelly's. p. 802.
  12. 1 2 Tan, SY; Tatsumura, Y (July 2015). "Alexander Fleming (1881–1955): Discoverer of penicillin". Singapore Medical Journal. 56 (7): 366–367. doi:10.11622/smedj.2015105. PMC   4520913 . PMID   26243971.
  13. ↑ FLEMING, ALEXANDER (September 1917). "The Physiological and Antiseptic Action of Flavine (With Some Observations on the Testing of Antiseptics)". The Lancet. 190 (4905): 341–345. doi:10.1016/S0140-6736(01)52126-1.
  14. 1 2 3 4 5 6 7 Allison, V. D. (1974). "Personal recollections of Sir Almroth Wright and Sir Alexander Fleming". The Ulster Medical Journal. 43 (2): 89–98. PMC   2385475 . PMID   4612919.
  15. 1 2 3 Fleming, A (1922). "On a remarkable bacteriolytic element found in tissues and secretions". Proceedings of the Royal Society B. 93 (653): 306–317. Bibcode:1922RSPSB..93..306F. doi: 10.1098/rspb.1922.0023 .
  16. 1 2 3 4 Lalchhandama, Kholhring (2020). "Reappraising Fleming's snot and mould". Science Vision. 20 (1): 29–42. doi: 10.33493/scivis.20.01.03 .
  17. ↑ Fleming, Alexander; Allison, V. D. (1922). "Observations on a Bacteriolytic Substance ("Lysozyme") Found in Secretions and Tissues". British Journal of Experimental Pathology. 3 (5): 252–260. PMC   2047739 .
  18. ↑ Salton, M. R. J. (1957). "The properties of lysozyme and its action on micororganisms". Bacteriological Reviews. 21 (2): 82–100. doi:10.1128/MMBR.21.2.82-100.1957. PMC   180888 . PMID   13436356.
  19. ↑ Schleifer, K. H.; Kloos, W. E.; Moore, A. (1972). "Taxonomic Status of Micrococcus luteus (Schroeter 1872) Cohn 1872: Correlation Between Peptidoglycan Type and Genetic Compatibility". International Journal of Systematic Bacteriology. 22 (4): 224–227. doi: 10.1099/00207713-22-4-224 .
  20. ↑ Young, Michael; Artsatbanov, Vladislav; Beller, Harry R.; Chandra, Govind; Chater, Keith F.; Dover, Lynn G.; Goh, Ee-Been; Kahan, Tamar; Kaprelyants, Arseny S.; Kyrpides, Nikos; Lapidus, Alla (2010). "Genome Sequence of the Fleming Strain of Micrococcus luteus, a Simple Free-Living Actinobacterium". Journal of Bacteriology. 192 (3): 841–860. doi:10.1128/JB.01254-09. PMC   2812450 . PMID   19948807.
  21. ↑ Canada, Environment and Climate Change (23 February 2018). "Final Screening Assessment of Micrococcus luteus strain ATCC 4698". aem. Retrieved 17 October 2020.
  22. ↑ Fleming, Alexander (1932). "Lysozyme". Proceedings of the Royal Society of Medicine. 26 (2): 71–84. doi: 10.1177/003591573202600201 . S2CID   209362460.
  23. 1 2 Fleming, A. (1945). "The Nobel Prize in Physiology or Medicine 1945 -Penicillin: Nobel Lecture". NobelPrize.org. Retrieved 17 October 2020.
  24. ↑ Gallo, Richard L. (2013). "The birth of innate immunity". Experimental Dermatology. 22 (8): 517. doi:10.1111/exd.12197. PMID   23879811. S2CID   23482849.
  25. ↑ Ragland, Stephanie A.; Criss, Alison K. (2017). "From bacterial killing to immune modulation: Recent insights into the functions of lysozyme". PLOS Pathogens. 13 (9): e1006512. doi:10.1371/journal.ppat.1006512. PMC   5608400 . PMID   28934357.
  26. ↑ Haven, Kendall F. (1994). Marvels of Science : 50 Fascinating 5-Minute Reads. Littleton, Colo: Libraries Unlimited. p. 182. ISBN   1-56308-159-8.
  27. ↑ Bigger, Joseph W.; Boland, C. R.; O'meara, R. A. Q. (1927). "Variant colonies ofStaphylococcus aureus". The Journal of Pathology and Bacteriology. 30 (2): 261–269. doi:10.1002/path.1700300204.
  28. ↑ Brown, K. (2004). Penicillin Man: Alexander Fleming and the Antibiotic Revolution. 320 pp. Sutton Publishing. ISBN   0-7509-3152-3.
  29. ↑ Hare, R. The Birth of Penicillin, Allen & Unwin, London, 1970
  30. ↑ Houbraken, Jos; Frisvad, Jens C.; Samson, Robert A. (2011). "Fleming's penicillin producing strain is not Penicillium chrysogenum but P. rubens". IMA Fungus. 2 (1): 87–95. doi:10.5598/imafungus.2011.02.01.12. PMC   3317369 . PMID   22679592.
  31. ↑ Hibbett, David S.; Taylor, John W. (2013). "Fungal systematics: is a new age of enlightenment at hand?". Nature Reviews Microbiology. 11 (2): 129–133. doi:10.1038/nrmicro2963. PMID   23288349. S2CID   17070407.
  32. 1 2 3 Hare, R. (1982). "New light on the history of penicillin". Medical History. 26 (1): 1–24. doi:10.1017/s0025727300040758. PMC   1139110 . PMID   7047933.
  33. ↑ Curry J (1981). "Obituary: C. J. La Touche". Medical Mycology. 19 (2): 164. doi:10.1080/00362178185380261.
  34. 1 2 3 Diggins FW (1999). "The true history of the discovery of penicillin, with refutation of the misinformation in the literature". British Journal of Biomedical Science. 56 (2): 83–93. PMID   10695047.
  35. ↑ Fleming, Alexander (1929). "On the antibacterial action of cultures of a Penicillium, with special reference to their use in the isolation of B. influenzae". British Journal of Experimental Pathology. 10 (3): 226–236. PMC   2041430 . PMID   2048009.; Reprinted as Fleming A (1979). "On the antibacterial action of cultures of a Penicillium, with special reference to their use in the isolation of B. influenzae". British Journal of Experimental Pathology. 60 (1): 3–13. PMC   2041430 .
  36. 1 2 Wainwright, Milton (1993). "The Mystery of the Plate: Fleming's Discovery and Contribution to the Early Development of Penicillin". Journal of Medical Biography. 1 (1): 59–65. doi:10.1177/096777209300100113. PMID   11639213. S2CID   7578843.
  37. ↑ "International Congress of Microbiology". British Medical Journal. 2 (3944): 307–310. 1936. doi:10.1136/bmj.2.3943.253. PMC   2457049 .
  38. ↑ Dixon, Bernard (1986). "A Salute to the Pioneers of Microbiology". Nature Biotechnology. 4 (8): 681. doi: 10.1038/nbt0886-681 . S2CID   37941905.
  39. ↑ "ANNOTATIONS". British Medical Journal. 2 (4208): 310–2. August 1941. doi:10.1136/bmj.2.4208.310. PMC   2162429 . PMID   20783842.
  40. ↑ Fleming A (September 1941). "Penicillin". British Medical Journal. 2 (4210): 386. doi:10.1136/bmj.2.4210.386. PMC   2162878 .
  41. ↑ in October 1943 Abraham proposed a molecular structure which included a cyclic formation containing three carbon atoms and one nitrogen atom, the β-lactam ring, not then known in natural products. This structure was not immediately published due to the restrictions of wartime secrecy, and was initially strongly disputed, by Sir Robert Robinson among others, but it was finally confirmed in 1945 by Dorothy Crowfoot Hodgkin using X-ray analysis." Oxford Dictionary of National Biography; "Abraham, Sir Edward Penley"
  42. ↑ Lowe, Gordon (13 May 1999). "Obituary: Sir Edward Abraham" . The Independent. London. Archived from the original on 4 October 2013.
  43. ↑ Yanes, Javier (6 August 2018). "Fleming and the Difficult Beginnings of Penicillin: Myth and Reality". OpenMind. Retrieved 7 June 2020.
  44. ↑ Moberg, C. (1991). "Penicillin's forgotten man: Norman Heatley". Science. 253 (5021): 734–735. Bibcode:1991Sci...253..734M. doi:10.1126/science.1876832. PMID   1876832.
  45. ↑ "Norman Heatley" . The Independent. 23 January 2004. Archived from the original on 16 November 2020. Retrieved 7 June 2020.
  46. ↑ Henry Harris, Howard Florey and the development of penicillin, a lecture given on 29 September 1998, at the Florey Centenary, 1898–1998, Sir William Dunn School of Pathology, Oxford University (sound recording)
  47. ↑ Conly, J.M.; Johnston, B.L. (2005). "Where are all the new antibiotics? The new antibiotic paradox". Canadian Journal of Infectious Diseases and Medical Microbiology. 16 (3): 159–160. doi: 10.1155/2005/892058 . PMC   2095020 . PMID   18159536.
  48. ↑ Wainwright, M.; Swan, H.T. (1987). "The Sheffield penicillin story". Mycologist. 1 (1): 28–30. doi:10.1016/S0269-915X(87)80022-8.
  49. 1 2 Wainwright, Milton (1990). "Besredka's "antivirus" in relation to Fleming's initial views on the nature of penicillin". Medical History. 34 (1): 79–85. doi:10.1017/S0025727300050286. PMC   1036002 . PMID   2405221.
  50. ↑ Wainwright, M (1987). "The history of the therapeutic use of crude penicillin". Medical History. 31 (1): 41–50. doi:10.1017/s0025727300046305. PMC   1139683 . PMID   3543562.
  51. ↑ Wainwright M, Swan HT (January 1986). "C.G. Paine and the earliest surviving clinical records of penicillin therapy". Medical History. 30 (1): 42–56. doi:10.1017/S0025727300045026. PMC   1139580 . PMID   3511336.
  52. 1 2 Howie, J. (1986). "Penicillin: 1929–40". British Medical Journal (Clinical Research Ed.). 293 (6540): 158–159. doi:10.1136/bmj.293.6540.158. PMC   1340901 . PMID   3089435.
  53. ↑ Glover, J. (1986). "The MRC and informed consent". British Medical Journal. 293 (6540): 157–158. doi:10.1136/bmj.293.6540.157. PMC   1340900 . PMID   3089434.
  54. ↑ Heaman, Elsbeth A. (2003). St Mary's: The History of a London Teaching Hospital. Montreal, Que.: McGill-Queen's University Press. p. 212. ISBN   978-0-7735-7086-3. OCLC   144085272.
  55. ↑ Marko, Vladimir (2020). From Aspirin to Viagra: Stories of the Drugs that Changed the World. Springer. pp. 105–106. doi:10.1007/978-3-030-44286-6_5. ISBN   978-3-030-44286-6. OCLC   1164582807. S2CID   241636139.
  56. 1 2 Rossiter, Peter (2005). "Keith Bernard Rogers". BMJ. 331 (7516): 579. doi:10.1136/bmj.331.7516.579-c. PMC   1200632 .
  57. ↑ Maurois, André (1963). The Life of Sir Alexander Fleming: Discoverer of Penicillin. Penguin Books. p. 156. ISBN   1-199-30814-5.
  58. ↑ Aronson, J. K. (1992). "Penicillin". European Journal of Clinical Pharmacology. 42 (1): 1–9. doi:10.1007/BF00314911. PMID   1541305.
  59. ↑ Kyle, Robert A.; Steensma, David P.; Shampo, Marc A. (2015). "Howard Walter Florey – Production of Penicillin". Mayo Clinic Proceedings. 90 (6): e63–64. doi: 10.1016/j.mayocp.2014.12.028 . PMID   26046419.
  60. ↑ Shama, Gilbert (2017). "Miracle near 34th street: Wartime Penicillin Research at St John's University, NY". Endeavour. 41 (4): 217–220. doi:10.1016/j.endeavour.2017.09.003. PMID   29055651.
  61. ↑ Morin, Robert B.; Gorman, Marvin (2014). Penicillins and Cephalosporins. Academic Press. pp. xxii. ISBN   978-1-4832-7719-6.
  62. ↑ Ward, John W.; Warren, Christian (2006). Silent Victories: The History and Practice of Public Health in Twentieth-Century America. Oxford University Press. p. 50. ISBN   978-0-19-974798-6.
  63. ↑ Kissick, William L. (1959). "The Life of Sir Alexander Fleming, Discoverer of Penicillin". The Yale Journal of Biology and Medicine. 32 (2): 140. PMC   2604061 .
  64. ↑ Wainwright, Milton (2002). "Fleming's unfinished". Perspectives in Biology and Medicine. 45 (4): 529–538. doi:10.1353/pbm.2002.0065. PMID   12388885. S2CID   32684352.
  65. ↑ Fleming, A (1942). "In-vitro Tests of Penicillin Potency". The Lancet. 239 (6199): 732–733. doi:10.1016/S0140-6736(00)70368-0.
  66. ↑ Bickel, L. Florey: The Man Who Made Penicillin, Sun Books, Melbourne, 1972. https://trove.nla.gov.au/work/21266280
  67. ↑ Abraham EP, Chain E, Holiday ER (1942). "Purification and Some Physical and Chemical Properties of Penicillin". British Journal of Experimental Pathology. 23 (3): 103–119. PMC   2065494 .
  68. ↑ Ligon, B. Lee (2004). "Sir Alexander Fleming: Scottish researcher who discovered penicillin". Seminars in Pediatric Infectious Diseases. 15 (1): 58–64. doi:10.1053/j.spid.2004.02.002. PMID   15175996.
  69. ↑ Cairns, H.; Lewin, W. S.; Duthie, E. S.; Smith, HonorV. (1944). "Pneumococcal Meningitis Treated with Penicillin". The Lancet. 243 (6299): 655–659. doi:10.1016/S0140-6736(00)77085-1.
  70. ↑ Fleming, Alexander (1943). "Streptococcal Meningitis treated With Penicillin". The Lancet. 242 (6267): 434–438. doi:10.1016/S0140-6736(00)87452-8.
  71. ↑ Mathews, John A. (2008). "The Birth of the Biotechnology Era: Penicillin in Australia, 1943–80". Prometheus. 26 (4): 317–333. doi:10.1080/08109020802459306. S2CID   143123783.
  72. ↑ Baldry, Peter (1976). The Battle Against Bacteria: A Fresh Look. CUP Archive. p. 115. ISBN   978-0-521-21268-7.
  73. ↑ Richards, A. N. (1964). "Production of penicillin in the United States (1941–1946)". Nature. 201 (4918): 441–445. Bibcode:1964Natur.201..441R. doi:10.1038/201441a0. PMID   14164615. S2CID   4296757.
  74. ↑ Fishman, Neil; Infectious Diseases Society of America; Pediatric Infectious Diseases Society (April 2012). "Policy statement on antimicrobial stewardship by the Society for Healthcare Epidemiology of America (SHEA), the Infectious Diseases Society of America (IDSA), & the Pediatric Infectious Diseases Society (PIDS)" (PDF). Infection Control & Hospital Epidemiology. 33 (4): 322–327. doi:10.1086/665010. PMID   22418625. S2CID   24828623. Archived (PDF) from the original on 9 October 2022.
  75. ↑ Rosenblatt-Farrell, Noah (2009). "The Landscape of Antibiotic Resistance". Environmental Health Perspectives. 117 (6): 244–150. doi:10.1289/ehp.117-a244. PMC   2702430 . PMID   19590668.
  76. ↑ Rammelkamp, Charles H.; Maxon, Thelma (1942). "Resistance of Staphylococcus aureus to the Action of Penicillin". Proceedings of the Society for Experimental Biology and Medicine. 51 (3): 386–389. doi:10.3181/00379727-51-13986. S2CID   87530495.
  77. ↑ Plough, Harold H. (1945). "Penicillin Resistance of Staphylococcus Aureus and its Clinical Implications". American Journal of Clinical Pathology. 15 (10): 446–451. doi:10.1093/ajcp/15.10.446. PMID   21005048.
  78. ↑ Biographical Index of Former Fellows of the Royal Society of Edinburgh 1783–2002 (PDF). The Royal Society of Edinburgh. July 2006. ISBN   0-902198-84-X. Archived from the original (PDF) on 24 January 2013. Retrieved 9 May 2016.
  79. ↑ Penicillin Man: Alexander Fleming and the Antibiotic Revolution. The History Press. September 2005. ISBN   0-7509-3153-1.
  80. ↑ US 2423873,Coghill, Robert D.& Moyer, Andrew J.,"Method for production of increased yields of penicillin",published 15 July 1947
  81. ↑ BartonMills.net local history. Retrieved 17 October 2016.
  82. ↑ Roberts, Michael; Ingram, Neil (2001). Biology (2, illustrated ed.). Nelson Thornes. p. 105. ISBN   0-7487-6238-8 . Retrieved 4 March 2012. Penicillin is just one of a very large number of drugs which today are used by doctors to treat people with diseases.
  83. ↑ "100,000 visitors in 6 days". National Museums Scotland. 3 August 2011. Archived from the original on 23 February 2012. Retrieved 4 March 2012.
  84. ↑ "No. 36544". The London Gazette (Supplement). 2 June 1944. p. 2566.
  85. ↑ "People of the century". P. 78. CBS News. Simon & Schuster, 1999
  86. ↑ Santesmases, María Jesús (18 December 2017). The Circulation of Penicillin in Spain: Health, Wealth and Authority. p. 39. ISBN   978-3-319-69718-5 . Retrieved 7 July 2020.
  87. ↑ "Alexander Fleming – Time 100 People of the Century". Time . 29 March 1999. Archived from the original on 16 October 2007.
  88. ↑ "Discovery and Development of Penicillin". International Historic Chemical Landmarks. American Chemical Society. Retrieved 21 August 2018.
  89. ↑ "BBC – Great Britons – Top 100". Internet Archive . Archived from the original on 4 December 2002. Retrieved 19 July 2017.
  90. 1 2 Edward Lewine (2007). "Death and the Sun: A Matador's Season in the Heart of Spain". p. 123. Houghton Mifflin Harcourt, 2007
  91. ↑ "Banknote designs mark Homecoming". BBC News. 14 January 2008. Archived from the original on 25 January 2009. Retrieved 20 January 2009.
  92. ↑ "Robert Burns voted Greatest Scot". STV Group . 30 November 2009. Archived from the original on 6 November 2018. Retrieved 7 February 2016.
  93. ↑ "Place name detail: Mount Fleming". New Zealand Gazetteer. New Zealand Geographic Board . Retrieved 21 August 2022.
  94. ↑ Gaynes, Robert (2017). "The Discovery of Penicillin – New Insights After More Than 75 Years of Clinical Use". Emerging Infectious Diseases. 23 (5): 849–853. doi:10.3201/eid2305.161556. PMC   5403050 .
  95. 1 2 Dufour, Héloïse D.; Carroll, Sean B. (2013). "History: Great myths die hard". Nature. 502 (7469): 32–33. doi: 10.1038/502032a . PMID   24137644.
  96. ↑ Ho, David (29 March 1999). "Bacteriologist Alexander Fleming". Time. ISSN   0040-781X . Retrieved 17 October 2020.
  97. ↑ Selwyn, Sydney (1980). "Howard Florey: the making of a great scientist". Journal of Medical Microbiology. 13 (3): 483. doi: 10.1099/00222615-13-3-483 .
  98. ↑ e.g., The Philadelphia Inquirer, 17 July 1945: Brown, Penicillin Man, note 43 to Chapter 2
  99. ↑ 14 November 1945; British Library Additional Manuscripts 56115: Brown, Penicillin Man, note 44 to Chapter 2
  100. ↑ see Wikipedia Discovery of penicillin article entry for 1920
  101. ↑ A History of May & Baker 1834–1984, Alden Press 1984.

Further reading

Academic offices
Preceded by Rector of the University of Edinburgh
1951–1954		Succeeded by
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.